RNIN
Bushido Capital US SMID Cap Equity ETF
Bushido Capital US SMID Cap Equity ETF seeks to provide long-term capital appreciation by investing primarily in U.S. small and mid-cap equity securities that are identified through a rules-based, quantitative investment process.
US
EQUITY
Active
MANAGEMENT STYLE
$ 159.8 M
ASSETS UNDER MGMT
70 bp
EXPENSES
Fund Basics
| Inception date | May 14, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| OSCAR HEALTH, INC. CLASS A | 2.1 % |
| MANNKIND CORP | 1.9 % |
| SYNNEX CORP | 1.8 % |
| PELOTON INTERACTIVE, INC. CLASS A | 1.8 % |
| PAGERDUTY, INC. | 1.7 % |
| TENABLE HOLDINGS, INC. | 1.7 % |
| CROCS INC | 1.7 % |
| PROGYNY, INC. | 1.6 % |
| PVH CORP | 1.6 % |
| ETSY, INC. | 1.6 % |
Constituent Breakdown
| Number of holdings | 79 |
| Herfindahl-Hirschman Index | 128 |
| Wgt avg mkt cap (mns) | $8,956 |
| Large cap (>$10bn) | 29.1% |
| Mid cap ($2-10bn) | 57.8% |
| Small cap (<$2bn) | 10.4% |
| Developed mkts. | 98.6% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 94.2 % |
 |
IRELAND | 1.5 % |
 |
MONACO | 1.1 % |
 |
SWITZERLAND | 1.1 % |
 |
BERMUDA | 1.0 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 15.8% | 28.4% | -- | -- | -- | -- | -- | 25.6% |
| Dividend Yield | 0.2% | 1.1% | -- | -- | -- | -- | -- | 1.1% |
| Total Returns | 16.0% | 29.6% | -- | -- | -- | -- | -- | 26.7% | Ann. Volatility | 15.1% | 14.6% | -- | -- | -- | -- | -- | 14.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.79 | 41% |
| MSCI EAFE | 0.51 | 28% |
| MSCI Emg Mkts | 0.32 | 19% |
Liquidity Measures
| Avg. volume (000) | 3 |
| ADV traded (mns) | $0 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.26% |
Technical Indicators
| 30d moving avg. (EMA) | $30.96 |
| Relative strength (RSI) | 63 |
| MACD/Signal | 0.29/0.24 |
| Bollinger Bands (Upper/Lower) | $32.17/$30.28 |
| Short interest (% of AUM) | 0.5% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. RNIN |
Expenses vs. RNIN |
ALTAR Score™ vs. RNIN |
|---|---|---|---|---|
| SFLO | VictoryShares Small Cap Free Cash Flow ETF | 51.3% | -21 bp | -2.4% |
| CALF | Pacer US Small Cap Cash Cows 100 ETF | 30.2% | -11 bp | -1.9% |
| DSMC | Distillate Small/Mid Cash Flow ETF | 20.1% | -15 bp | -0.7% |
| FLOW | Global X U.S. Cash Flow Kings 100 ETF | 19.0% | -45 bp | -0.2% |
| ECML | Euclidean Fundamental Value ETF | 16.4% | +25 bp | -2.2% |
| CAFG | Pacer US Small Cap Cash Cows Growth Leaders ETF | 13.5% | -11 bp | -6.8% |
| AFMC | First Trust Active Factor Mid Cap ETF | 13.3% | -5 bp | -4.0% |
| VAMO | Cambria Value & Momentum ETF | 11.8% | -9 bp | -5.1% |
| SRHQ | SRH U.S. Quality ETF | 11.7% | -35 bp | -4.7% |
| SMCF | Themes US Small Cap Cash Flow Champions ETF | 11.6% | -41 bp | -0.5% |
Risk and Returns: RNIN vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/3/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
11.6%
ALTAR SCORE™
99th
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 1,399 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. RNIN's ALTAR Score™ is approximately 3.0 standard
deviations above the category average. This places RNIN in the 99th percentile
among funds in the category.
Sell-Side Consensus
$37.35
PRICE TARGET
+15.4%
UPSIDE